George Frodsham

CEO at MediSieve Limited

Speaker

Dr Frodsham is the founder and CEO of MediSieve, a London-based biotech developing a platform to deplete specific substances from the bloodstream. As CEO, Dr. Frodsham has raised over £4m for the company. His background is in Physics and Engineering, with a BSc/BA in Physics and Philosophy, a MSc in Nanotechnology and a PhD in Biochemical Engineering. Dr Frodsham is also the recipient of a number of awards, including the BBSRC Innovator of the Year award and was named on the MIT Technology Review's "35 Under 35" list. George's work is currently featured in the Science Museum in London.

George will be presenting MediSieve's latest work depleting AAV neutralising antibodies from the bloodstream to enable AAV gene therapies to be used on seropositive patients